Choy, J.Suarez Rodriguez, C.Larkin, J.Patel, P.Perez Valderrama, B.Rodriguez-Vida, A.Glen, H.Thistlethwaite, F.Ralph, C.Srinivasan, G.Mendez Vidal, M. J.Carter, A.Tyson, C.Prendergast, A.Mousa, K.Powles, T. B.Szabados, B. E.2025-01-072025-01-072020-12-010923-7534https://hdl.handle.net/10668/27421enOutcomes with durvalumab and savolitinib in metastatic papillary renal cancer (mPRC) according to international metastatic renal cell carcinoma database consortium (IMDC) risk groupsconference outputopen access10.1016/j.annonc.2020.10.5571569-8041http://www.annalsofoncology.org/article/S0923753420430704/pdf600992500070